Shamim presented a poster on the diagnosis and surveillance of bladder cancer – specifically the use of a novel histochemical stain, CellDetect, which can distinguish between malignant and benign urothelial cells with higher sensitivity and specificity than standard urine cytology.
She concluded that CellDetect is useful as an additional test in cases where standard urine cytology is atypical or indeterminate, and could be particularly valuable in the adjunctive monitoring of low-risk patients for whom non-invasive surveillance is not recommended.
While the non-gynae portion of the programme focused on advances in non-invasive diagnostic techniques, the gynae part centred on HPV-based screening programmes for cervical cancer. Representatives from Sweden, Norway, Finland and beyond shared their own experiences of implementing primary HPV testing and the impact this has had on their national cervical screening programmes.
As a conference highlighting so many of the innovative and exciting developments occurring within cytology at the moment, HSL was delighted to sponsor Shamim to attend ECC 2018 and share her research on an international stage.